Mereo BioPharma Group

$3.53
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today
+$0.02 (+0.57%) As of 10:26 PM UTC after-hours

Why Robinhood?

You can buy or sell MREO and other stocks, options, and ETFs commission-free!

About MREO

Mereo BioPharma Group plc American Depositary Shares, also called Mereo BioPharma Group, is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its portfolio include Etigilimab (MPH-313), Alvelestat (MPH-966), Setrusumab (BPS-804), Navicixizumab (OMP-305B83), Acumapimod (BCT-197), and Leflutrozole (BGS-649).

CEO
Denise Vera Scots-Knight
Employees
38
Headquarters
London, Greater London
Founded
2015
Market Cap
371.56M
Price-Earnings Ratio
Dividend Yield
Average Volume
2.88M
High Today
$3.58
Low Today
$3.40
Open Price
$3.52
Volume
1.40M
52 Week High
$4.71
52 Week Low
$1.03

MREO Earnings

Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Available Mar 31, After Hours

You May Also Like

SCHR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure